Floatz logo

Florbetaben

Amyloid Beta-Protein

Lantheus Biosciences Ltd.Small moleculePhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Amyloid Beta-Protein cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Florbetaben is also rated in:

Cardiac AmyloidosisDormant
BBB
Indicative ·
73 / 100
View asset →
Alzheimer diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
AL amyloidosisDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →